AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal (NASDAQ:AZN)
In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to accumulate U.S. vaccine ...
Tag: Icosavax
In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to accumulate U.S. vaccine ...